Abstract

BackgroundCounter-pulsation control (CPC) by ventricular assist devices (VADs) is believed to reduce cardiac load and increase coronary perfusion. However, patients with VADs have a higher risk of arrhythmia, which may cause the CPC to fail. Consequently, CPC has not been applied by VADs in clinical practice. The phase-locked loop (PLL) algorithm for CPC is readily implemented in VADs; however, it requires a normal, consistent heartbeat for adequate performance. When an arrhythmia occurs, the algorithm maintains a constant pumping rate despite the unstable heartbeat. Therefore, to apply the PLL algorithm to CPC, the hemodynamic effects of abnormal heartbeats must be analyzed.ObjectivesThis study sought to predict the hemodynamic effects in patients undergoing CPC using VADs, based on electrocardiogram (ECG) data, including a wide range of heart rate (HR) changes caused by premature ventricular contraction (PVC) or other reasons.MethodsA four-element Windkessel hemodynamic model was used to reproduce the patient’s aortic blood pressure in this study. ECG data from 15 patients with severe congestive heart failure were used to assess the effect of the CPC on the patients’ hemodynamic state. The input and output flow characteristics of the pulsatile VAD (LibraHeart I, Cervika, Korea) were measured using an ultrasound blood flow meter (TS410, Transonic, USA), with the aortic pressure maintained at 80–120 mmHg. All other patient conditions were also reproduced.ResultsIn patients with PVCs or normal heartbeats, CPC controlled by a VAD reduced the cardiac load by 20 and 40%, respectively. When the HR was greater for other reasons, such as sinus tachycardia, simultaneous ejection from the heart and VAD was observed; however, the cardiac load was not increased by rapid cardiac contractions resulting from decreased left ventricle volume. These data suggest that the PLL algorithm reduces the cardiac load and maintains consistent hemodynamic changes.

Highlights

  • Counter-pulsation control (CPC) by ventricular assist devices (VADs) is believed to reduce cardiac load and increase coronary perfusion

  • In patients with premature ventricular contraction (PVC) or normal heartbeats, CPC controlled by a VAD reduced the cardiac load by 20 and 40%, respectively

  • When the heart rate (HR) was greater for other reasons, such as sinus tachycardia, simultaneous ejection from the heart and VAD was observed; the cardiac load was not increased by rapid cardiac contractions resulting from decreased left ventricle volume

Read more

Summary

Introduction

Counter-pulsation control (CPC) by ventricular assist devices (VADs) is believed to reduce cardiac load and increase coronary perfusion. Patients with VADs have a higher risk of arrhythmia, which may cause the CPC to fail. Patients with VADs are at a higher risk of developing arrhythmia, which can induce CPC failure [10, 11]. Prior to engaging in CPC, it should be confirmed that failure of the VAD will not cause the patient’s hemodynamic state or cardiac load to worsen. Clinical studies involving CPC are complicated despite the increasing use of VAD applications. This is because many reports have suggested that VADs should not be used for patients with arrhythmias [13,14,15]. The CPC algorithm of VADs should predict future heartbeats based on prior heartbeats, and preemptively provide subsequent pulses [12]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call